Kabir S, Rosenstreich D L
Infect Immun. 1977 Jan;15(1):156-64. doi: 10.1128/iai.15.1.156-164.1977.
The early events in lipopolysaccharide (LPS)-induced B-cell activation were investigated by studying the binding of 14C-labeled LPS to murine lymphocytes in vitro. In these studies we utilized intrinsically labeled 14C-labeled LPS from Salmonella minnesota or the 14C-labeled glycolipid derived from the Re mutant of S. minnesota (R595). Bone marrow-derived (B) lymphocytes bound more LPS than did thymus-derived (T) lymphocytes. Binding of LPS to murine spleen lymphocytes from strain C3H/HeN was compared with the binding to spleen lymphocytes from strain C3H/HeJ, a strain resistant to certain biological activities of LPS including mitogenesis. Spleen cells from both strains bound LPS equally well, suggesting that unresponsiveness of C3H/HeJ mice to LPS is due to factors other than a defect in binding of LPS. LPS binding to cells appeared to be due to a nonspecific interaction between the lipid moiety of LPS and the lipid components of the cell membrane. Thus, the highly lipophilic, polysaccharide-deficient glycolipid from R595 bound at least 20 times better than did LPS. Furthermore, partial removal of cell surface proteins with trypsin or sialic acids with neuraminidase enhanced glycolipid binding, suggesting that binding is not through a protein- or sialic acid-containing receptor. The binding of glycolipid to lymphocytes was only partially specific since unlabeled glycolipid R595, lipid A, and LPS did not completely inhibit the uptake of 14C-labeled glycolipid R595. In addition, binding could be inhibited by a nonmitogenic phospholipid (phosphatidyl ethanolamine), which also is consistent with a nonspecific lipid-lipid interaction. Experiments were performed to determine the relationship of LPS binding to lymphocyte activation in the lymphocytes. The process of activation of lymphocytes by LPS was a slow one, since LPS was required to be present in culture for at least 24 h in order to obtain significant lymphocyte activation, suggesting that the amounts of LPS bound earlier are either quantitatively or qualitatively insufficient to irreversibly activate the cell.
通过研究体外14C标记的脂多糖(LPS)与小鼠淋巴细胞的结合,对LPS诱导的B细胞活化早期事件进行了研究。在这些研究中,我们使用了来自明尼苏达沙门氏菌的内源性标记的14C标记的LPS或源自明尼苏达沙门氏菌(R595)Re突变体的14C标记的糖脂。骨髓来源的(B)淋巴细胞比胸腺来源的(T)淋巴细胞结合更多的LPS。将C3H/HeN品系小鼠脾脏淋巴细胞对LPS的结合与C3H/HeJ品系小鼠脾脏淋巴细胞的结合进行了比较,C3H/HeJ品系对包括有丝分裂原在内的LPS的某些生物学活性具有抗性。两个品系的脾细胞对LPS的结合同样良好,这表明C3H/HeJ小鼠对LPS无反应是由于LPS结合缺陷以外的因素。LPS与细胞的结合似乎是由于LPS的脂质部分与细胞膜的脂质成分之间的非特异性相互作用。因此,来自R595的高度亲脂性、多糖缺陷型糖脂的结合能力至少比LPS强20倍。此外,用胰蛋白酶部分去除细胞表面蛋白或用神经氨酸酶去除唾液酸可增强糖脂结合,这表明结合不是通过含蛋白质或唾液酸的受体进行的。糖脂与淋巴细胞的结合只是部分特异性的,因为未标记的糖脂R595、脂质A和LPS并不能完全抑制14C标记的糖脂R595的摄取。此外,结合可被一种无丝分裂原性的磷脂(磷脂酰乙醇胺)抑制,这也与非特异性脂质-脂质相互作用一致。进行实验以确定淋巴细胞中LPS结合与淋巴细胞活化之间的关系。LPS激活淋巴细胞的过程是一个缓慢的过程,因为为了获得显著的淋巴细胞活化,需要在培养物中至少存在LPS 24小时,这表明早期结合的LPS量在数量上或质量上不足以不可逆地激活细胞。